510(k) · Cleared
ClearedL-Mesitran Hydro, L-Mesitran Border, L-Mesitran Net, L-Mesitran Active
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Theo Manufacturing BV · FRO Dressing, Wound, Drug
Cleared on Jul 25, 2007 as substantially equivalent to K872165 (Southwest Technologies, Inc., 1987) after a 575-day review. Its family tree reaches back 1 generation to 1987. 3 later devices descend from it.
- Decided
- Jul 25, 2007
- Review
- 575 days
- Class
- Class U
- Product code
- FRO
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K872165 (1987). 3 later devices descend from it, 2 citing it directly.
- Root · 1 generation backK872165 Elasto-Gel Occlusive DressingSouthwest Technologies, Inc. · 1987 · Recalled
- This deviceK053613 L-Mesitran Hydro, L-Mesitran Border, L-Mesitran Net, L-Mesitran ActiveTheo Manufacturing BV · 2007
- Descendant · cites it directly · 1 of its ownK110546 Medihoney Hydrogel Sheet Dressings with Active Leptospermum HoneyDerma Sciences, Inc. · 2011 · Recalled
- Descendant · 2 generations on · 0 of its ownK222143 Apis (R), Veris (TM)Sweetbio, Inc. · 2023
- Descendant · cites it directly · 0 of its ownK150676 L-Mesitran Dressing Family II- Soft and TulleTheo Manufacturing BV · 2015
Most influential descendants
Showing 3 of 3 · See all- K110546Medihoney Hydrogel Sheet Dressings with Active Leptospermum HoneyDerma Sciences, Inc. · 2011 · cites it directly1descendant
- K222143Apis (R), Veris (TM)Sweetbio, Inc. · 2023 · 2 generations on0descendants
- K150676L-Mesitran Dressing Family II- Soft and TulleTheo Manufacturing BV · 2015 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K872165 | Elasto-Gel Occlusive Dressing | Southwest Technologies, Inc. | 1987 | 2 |
| 0 (this device) | K053613 | L-Mesitran Hydro, L-Mesitran Border, L-Mesitran Net, L-Mesitran Active | Theo Manufacturing BV | 2007 | — |
| +1 | K110546 | Medihoney Hydrogel Sheet Dressings with Active Leptospermum Honey | Derma Sciences, Inc. | 2011 | 5 |
| +2 | K222143 | Apis (R), Veris (TM) | Sweetbio, Inc. | 2023 | — |
| +1 | K150676 | L-Mesitran Dressing Family II- Soft and Tulle | Theo Manufacturing BV | 2015 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2011 | 1 | 0 |
| 2015 | 1 | 0 |
| 2023 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in FRO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new FRO device
- #1 K261023 Microdacyn Wound Irrigation Solutionscore 15.5 · 14 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K872165 | Elasto-Gel Occlusive DressingSummary page 1…n Name: Wound Dressing Classification Code: Dressing, Product Code FRO Predicate Device: Southwest Technologies' Elasto-Gel Dressings, #K872165 Device Description: L-Mesitran Hydro, L-Mesitran Border, and L-Mesitran Active are hydro-act… | 1987 |
What descends from it? (3)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All FRO devicesFRO Dressing, Wound, Drug: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · FRO
11in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · FRO
176in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · FRO
2in 2024
Class I (2 since 2007) Class II/III not classified
Adverse event reports per year · FRO
192in 2025
MAUDE reports naming product code FRO, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 29 | 187 | 4 | 55 |
| 2008 | 26 | 130 | 1 | 30 |
| 2009 | 31 | 136 | 1 | 45 |
| 2010 | 31 | 146 | 0 | 122 |
| 2011 | 27 | 177 | 4 | 42 |
| 2012 | 24 | 96 | 0 | 65 |
| 2013 | 19 | 194 | 1 | 139 |
| 2014 | 22 | 214 | 1 | 269 |
| 2015 | 28 | 249 | 2 | 297 |
| 2016 | 28 | 222 | 3 | 147 |
| 2017 | 23 | 147 | 1 | 149 |
| 2018 | 20 | 206 | 0 | 128 |
| 2019 | 16 | 270 | 1 | 136 |
| 2020 | 12 | 226 | 0 | 139 |
| 2021 | 8 | 275 | 6 | 183 |
| 2022 | 9 | 332 | 2 | 176 |
| 2023 | 18 | 283 | 2 (2) | 198 |
| 2024 | 24 | 263 | 2 | 232 |
| 2025 | 11 | 176 | 0 | 192 |
| 2026 | 17 | 254 | 2 | — |
What is it indicated for?
L-Mesitran Hydro and L-Mesitran Border L-Mesitran Hydro and Border dressings are indicated for acute and chronic superficial wounds such as: bruises, cuts, bedsores, first and second-degree burns and other traumatic wounds, venous and arterial ulcera, diabetes ulcers, donor sites, and post-operative wounds. L-Mesitran Hydro and Border should not be used as a covering for deep narrow cavities, dirty wounds (these should first be cleansed), third-degree…
Read the full statement (172 words)
L-Mesitran Hydro and L-Mesitran Border
L-Mesitran Hydro and Border dressings are indicated for acute and chronic superficial wounds such as: bruises, cuts, bedsores, first and second-degree burns and other traumatic wounds, venous and arterial ulcera, diabetes ulcers, donor sites, and post-operative wounds.
L-Mesitran Hydro and Border should not be used as a covering for deep narrow cavities, dirty wounds (these should first be cleansed), third-degree burns and fistulae.
L-Mesitran Net
L-Mesitran Net Dressings are indicated for acute and chronic superficial wounds such as: bruises, skin tears, pressure ulcers, venous and arterial ulcera, diabetes ulcers, donor sites, cuts, first and second degree burns, postoperative wounds and other external wounds caused by trauma. L-Mesitran Net is to be used in conjunction with other secondary dressings.
It should not be used on its own as a covering for dirty, infected and heavily exudating wounds (should first be cleansed), third degree burns, or deep narrow cavities.
L-Mesitran Active
L-Mesitran Active Dressings are indicated for treating minor burns, superficial cuts, lacerations and abrasions, and other small wounds.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K053613 · printed Nov 6, 2026
Cite this page
510(k) Report. “K053613: L-Mesitran Hydro, L-Mesitran Border, L-Mesitran Net, L-Mesitran Active.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K053613
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026